Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Why Viking Therapeutics Stock Is Heating Up Today
02:49pm, Wednesday, 31'st May 2023
Roth Capital Partners initiated coverage on Viking Therapeutics with a $32 per-share price target. The private investment banking firm also appears confident in the prospects of the company's lead ass
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
05:38am, Tuesday, 30'th May 2023
Two stocks in the healthcare sector have already doubled this year, and they could climb much higher, according to Wall Street. Viking Therapeutics is a clinical-stage biotech with an experimental tre
3 Biotech Stocks Sitting on Huge-Upside Catalysts
06:19am, Friday, 26'th May 2023
Now is a great time to start accumulating top biotech stocks. The biotech boom is red-hot.
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich
06:40am, Monday, 22'nd May 2023
These biotech stocks are swinging for the fences. They may hit homers, they may strike out.
7 Stocks That Wall Street Analysts Are Loving in May
03:28pm, Sunday, 21'st May 2023
Stock screeners can help investors identify stocks to buy based on a variety of criteria. In fact, one helpful predictor of stock price growth can be found with analyst ratings.
TipRanks reveals the top 10 health care sector analysts of the past decade
08:20am, Sunday, 21'st May 2023
TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.
Why Viking Therapeutics Stock Is Buckling Today
02:52pm, Thursday, 18'th May 2023
The FTC's attempt to block the merger between Amgen and Horizon Therapeutics is weighing on small- and mid-cap biotech stocks. Shares of Viking Therapeutics are sinking in lockstep with its broader pe
Viking (VKTX) Up 12% as VKTX-2809 Meets Goals in NASH Study
03:06pm, Wednesday, 17'th May 2023
A mid-stage study data shows that Viking Therapeutics' (VKTX) VK2809 achieved reductions in liver fat content in patients with biopsy-confirmed NASH, following 12-weeks of treatment.
Why Viking Therapeutics Stock Bolted Higher Today
03:52pm, Tuesday, 16'th May 2023
Viking's long-awaited midstage NASH trial results were announced today, and they didn't disappoint. Investors bid up the biotech's shares in response to this positive clinical update, despite a dour d
Top 1% Biotech Viking Therapeutics Backs Off Its Record Run On NASH Enthusiasm
11:29am, Tuesday, 16'th May 2023
Viking unveiled promising test results Tuesday for a liver disease drug, but VKTX stock reversed its premarket gain and sank at the open. The post Top 1% Biotech Viking Therapeutics Backs Off Its Reco
Bulls Blast Viking Therapeutics Stock on Trial Data
10:24am, Tuesday, 16'th May 2023
Viking Therapeutics Inc (NASDAQ:VKTX) today announced a win for its experimental drug to treat patients with a type of fatty liver disease called non-alcoholic steatohepatitis (NASH).
Why Top 1% Biotech Viking Therapeutics Is At The Brink Of A Record High
09:32am, Tuesday, 16'th May 2023
Viking Therapeutics unveiled promising test results Tuesday for a liver disease treatment, sending top-rated VKTX stock to a record high. The post Why Top 1% Biotech Viking Therapeutics Is At The Brin
Why Viking Therapeutics Stock Wobbled Today
03:40pm, Tuesday, 09'th May 2023
Viking Therapeutics' sizzling upswing took a slight breather this morning. However, most shareholders appear to have held on through today's volatility.
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
04:28pm, Monday, 01'st May 2023
Biotech stocks were fairly volatile today, thanks to another buyout and a spate of earnings reports. Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics were among the most volatile in t
Why Viking Therapeutics Stock Briefly Popped Today
02:56pm, Thursday, 27'th Apr 2023
H.C. Wainwright raised its price target on the biotech stock from $21 to $33 a share. Bullish investors on the stock seemingly took this as a strong buy signal.
